Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings (Q33425487)

26 July 2017

1 reference

title

Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings (English)

1 reference

magnetic resonance imaging

26 July 2017

0 references

P Dazzan

2

0 references

author name string

S Navari

series ordinal

1

1 reference

PubMed ID

19338710

26 July 2017

language of work or name

English

0 references

publication date

2 April 2009

1 reference

26 July 2017

15

1 reference

inferred from page(s)

published in

Psychological Medicine

1 reference

26 July 2017

39

1 reference

26 July 2017

1763-1777

1 reference

26 July 2017

11

1 reference

Risperidone in first-episode psychosis: a longitudinal, exploratory voxel-based morphometric study

26 July 2017

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

Effect of clozapine on caudate nucleus volume in relation to symptoms of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

The effect of clozapine on caudate nucleus volume in schizophrenic patients previously treated with typical antipsychotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

Dorsal striatal size, shape, and metabolic rate in never-medicated and previously medicated schizophrenics performing a verbal learning task.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

Cerebral cortical gray expansion associated with two second-generation antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

Quetiapine regulates FGF-2 and BDNF expression in the hippocampus of animals treated with MK-801.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

A serial longitudinal quantitative MRI study of cerebral changes in first-episode schizophrenia using image segmentation and subvoxel registration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

Childhood-onset schizophrenia: brain MRI rescan after 2 years of clozapine maintenance treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

Mechanisms of typical and atypical antipsychotic drug action in relation to dopamine and NMDA receptor hypofunction hypotheses of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

A randomized, controlled comparison of the efficacy and tolerability of low and high doses of haloperidol in the treatment of first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

Magnetic resonance imaging of the thalamus in male patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

The effect of antipsychotic medication on relative cerebral blood perfusion in schizophrenia: assessment with technetium-99m hexamethyl-propyleneamine oxime single photon emission computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

Antipsychotic-associated neuronal changes in the brain: toxic, therapeutic, or irrelevant to the long-term outcome of schizophrenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

Effect of antipsychotics on regional cerebral blood flow measured with positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

N-Methyl-D-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

An MRI study of midbrain morphology in patients with schizophrenia: relationship to psychosis, neuroleptics, and cerebellar neural circuitry

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

Caudate size in first-episode neuroleptic-naive schizophrenic patients measured using an artificial neural network.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

Regional change in brain morphometry in schizophrenia associated with antipsychotic treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

MRI anatomy of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

Duration of illness and treatment effects on hippocampal volume in male patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

Volume changes in gray matter in first-episode neuroleptic-naive schizophrenic patients treated with risperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

Brain volume changes in first-episode schizophrenia: a 1-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

Antipsychotic drug effects on brain morphology in first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

MRI correlates of treatment response in first episode psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

Effect of chronic olanzapine treatment on nerve growth factor and brain-derived neurotrophic factor in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

Longitudinal study of brain morphology in first episode schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

Effects of haloperidol metabolites on neurotransmitter uptake and release: possible role in neurotoxicity and tardive dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

Effects of antipsychotic drugs on neurogenesis in the forebrain of the adult rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

An MRI study of basal ganglia volumes in first-episode schizophrenia patients treated with risperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

Hippocampal volume in first-episode psychoses and chronic schizophrenia: a high-resolution magnetic resonance imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

Cortical thinning in cingulate and occipital cortices in first episode schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

Volume increases in striatum associated with positive symptom reduction in schizophrenia: a preliminary observation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

Caudate volume changes in first episode psychosis parallel the effects of normal aging: a 5-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

Changes in caudate volume after exposure to atypical neuroleptics in patients with schizophrenia may be sex-dependent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

Effects of chronic haloperidol and clozapine treatment on neurogenesis in the adult rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

A review of MRI findings in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

An update of fast-off dopamine D2 atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

Effects of antipsychotics on brain structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

7 January 2021

Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

7 January 2021

Reduced basal ganglia volumes after switching to olanzapine in chronically treated patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

7 January 2021

Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

7 January 2021

Changes in caudate volume with neuroleptic treatment

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

7 January 2021

Induction of NF-kappaB activity during haloperidol-induced oxidative toxicity in clonal hippocampal cells: suppression of NF-kappaB and neuroprotection by antioxidants.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

7 January 2021

Reduced thalamic volume in patients with chronic schizophrenia after switching from typical antipsychotic medications to olanzapine.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

7 January 2021

Dynamics of gray matter loss in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

7 January 2021

Reduced dorsal and orbital prefrontal gray matter volumes in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

7 January 2021

Atypical Antipsychotics: Mechanism of Action

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709005315

7 January 2021

10.1017/S0033291709005315

Identifiers

DOI

1 reference

26 July 2017

1 reference

PubMed ID

19338710